{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T04:18:20Z","timestamp":1786853900126,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.jconrel.2004.09.004","type":"journal-article","created":{"date-parts":[[2004,12,6]],"date-time":"2004-12-06T19:30:37Z","timestamp":1102361437000},"page":"357-377","source":"Crossref","is-referenced-by-count":16,"title":["Conjugation of an antibody to cross-linked fibrin for targeted delivery of anti-restenotic drugs"],"prefix":"10.1016","volume":"100","author":[{"given":"Anita C.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie H.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2004.09.004_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0163-7258(01)00153-X","article-title":"Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy","volume":"91","author":"Bennett","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2004.09.004_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.RVI.0000058423.01661.57","article-title":"Drug-eluting stents: potential applications for peripheral arterial occlusive disease","volume":"14","author":"Duda","year":"2003","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.jconrel.2004.09.004_bib3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/(SICI)1522-726X(199911)48:3<324::AID-CCD20>3.0.CO;2-K","article-title":"Preventive effects of the heparin-coated stent on restenosis in the porcine model","volume":"48","author":"Ahn","year":"1999","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2004.09.004_bib4","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1161\/01.CIR.0000069330.41022.90","article-title":"New frontiers in cardiology. Drug-eluting stents: part 1","volume":"107","author":"Sousa","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1050-1738(03)00038-0","article-title":"Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents","volume":"12","author":"Indolfi","year":"2003","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.jconrel.2004.09.004_bib6","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/01.CIR.0000071083.31270.C3","article-title":"Endothelial recovery. The next target in restenosis prevention","volume":"107","author":"Losordo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000074282","article-title":"Delayed recovery of receptor-mediated functional responses to acetylcholine in mouse isolated carotid arteries following endothelial denudation in vivo","volume":"40","author":"Miller","year":"2003","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.jconrel.2004.09.004_bib8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/nm1102-1249","article-title":"Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies","volume":"8","author":"Dzau","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2004.09.004_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0165-6147(00)01505-4","article-title":"Restenosis: a challenge for pharmacology","volume":"21","author":"Bult","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2004.09.004_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/01.CIR.89.2.770","article-title":"Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis","volume":"89","author":"Edelman","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib11","doi-asserted-by":"crossref","first-page":"11111","DOI":"10.1073\/pnas.96.20.11111","article-title":"Tissue concentration of heparin, not administered dose, correlates with the biological response of injured arteries in vivo","volume":"96","author":"Lovich","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2004.09.004_bib12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.CIR.88.3.1215","article-title":"Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration","volume":"88","author":"Rogers","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0008-6363(97)00155-7","article-title":"Local drug delivery systems and prevention of restenosis","volume":"35","author":"Brieger","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jconrel.2004.09.004_bib14","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/hc3601.093987","article-title":"Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model","volume":"104","author":"Suzuki","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0049-3848(03)00109-9","article-title":"Timecourse of fibrin deposition and removal after arterial injury","volume":"109","author":"Thomas","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jconrel.2004.09.004_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1432-1033.1989.tb15095.x","article-title":"Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin","volume":"185","author":"Dewerchin","year":"1989","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jconrel.2004.09.004_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(91)90163-N","article-title":"A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates","volume":"194","author":"Zara","year":"1991","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2004.09.004_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/10428199309145753","article-title":"Effects of the intermolecular toxin-monoclonal antibody linkage on the in vivo stability, immunogenicity and anti-leukemic activity of B43 (anti-CD19) pokeweed antiviral protein immunotoxin","volume":"9","author":"Uckun","year":"1993","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jconrel.2004.09.004_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrd984","article-title":"Therapeutic antibodies for human diseases at the dawn of the twenty-first century","volume":"2","author":"Brekke","year":"2003","journal-title":"Nat. Rev., Drug Discov."},{"key":"10.1016\/j.jconrel.2004.09.004_bib20","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1172\/JCI119038","article-title":"Rapamycin inhibits vascular smooth muscle cell migration","volume":"98","author":"Poon","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2004.09.004_bib21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/labinvest.3780298","article-title":"Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model","volume":"81","author":"Roque","year":"2001","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jconrel.2004.09.004_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1053-2498(02)00525-9","article-title":"TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit?","volume":"22","author":"Mehra","year":"2003","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.jconrel.2004.09.004_bib23","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.jtcvs.2003.03.004","article-title":"Rapamycin has no effect on fibrosis-associated gene expression or extracellular matrix accumulation when administered to animals with established or early allograft vasculopathy","volume":"126","author":"Murphy","year":"2003","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jconrel.2004.09.004_bib24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00007890-199503150-00002","article-title":"Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement","volume":"59","author":"Gregory","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00005344-199906000-00001","article-title":"Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin","volume":"33","author":"Burke","year":"1999","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jconrel.2004.09.004_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0165-6147(00)89022-7","article-title":"Therapeutic uses of heparin beyond its traditional role as an anticoagulant","volume":"16","author":"Tyrrell","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2004.09.004_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4684-0946-8_1","article-title":"The chemistry of heparin","volume":"52","author":"Jeanloz","year":"1975","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jconrel.2004.09.004_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0008-6215(93)84259-9","article-title":"\u201cFast moving\u201d and \u201cslow moving\u201d heparins, dermatan sulfate, and chondroitin sulfate: qualitative and quantitative analysis by agarose-gel electrophoresis","volume":"247","author":"Volpi","year":"1993","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.jconrel.2004.09.004_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/bbrc.1997.7687","article-title":"Influence of molecular weight, protein core and charge of native heparin fractions on pulmonary artery smooth muscle cell proliferation","volume":"241","author":"Joseph","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2004.09.004_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4899-2444-5_4","article-title":"New methodologies in heparin structure analysis and the generation of LMW heparins","volume":"313","author":"Linhardt","year":"1992","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jconrel.2004.09.004_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0165-2478(84)90008-7","article-title":"A novel procedure for labelling immunoglobulins by conjugation to oligosaccharide moieties","volume":"8","author":"O'Shannessy","year":"1984","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jconrel.2004.09.004_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1042\/bj2670585","article-title":"Reversible and irreversible cross-linking of immunoglobulin heavy chains through their carbohydrate residues","volume":"267","author":"Heimgartner","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2004.09.004_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0003-2697(86)90176-4","article-title":"Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions","volume":"156","author":"Staros","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2004.09.004_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2004.05.006","article-title":"Targeted delivery of heparin and LMWH using a fibrin antibody prevents restenosis","volume":"176","author":"Thomas","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jconrel.2004.09.004_bib35","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1161\/01.CIR.94.12.3291","article-title":"Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer","volume":"94","author":"Asahara","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib36","first-page":"189","article-title":"Differences in response of rat and rabbit arteries to injury","volume":"11","author":"Thomas","year":"2000","journal-title":"Biomed. Res."},{"key":"10.1016\/j.jconrel.2004.09.004_bib37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.79.3.657","article-title":"Effects of thrombin inhibition of the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor","volume":"79","author":"Heras","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0049-3848(90)90097-V","article-title":"The simpliRED D dimer test: a novel assay for the detection of crosslinked fibrin degradation products in whole blood","volume":"58","author":"John","year":"1990","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jconrel.2004.09.004_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0002-9610(84)90219-8","article-title":"Clinical evaluation of a new rapid heparin assay using the dye azure A","volume":"148","author":"Gundry","year":"1984","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.jconrel.2004.09.004_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0003-2697(87)90658-0","article-title":"Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride","volume":"161","author":"Chandrasekhar","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2004.09.004_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/abio.1993.1098","article-title":"Combined alcian blue and silver staining of subnanogram quantities of proteoglycans and glycosaminoglycans in sodium dodecyl sulfate-polyacrylamide gels","volume":"209","author":"Moller","year":"1993","journal-title":"Anal. Biochem."},{"issue":"Suppl. B","key":"10.1016\/j.jconrel.2004.09.004_bib42","doi-asserted-by":"crossref","first-page":"B14","DOI":"10.1016\/S0149-2918(00)89019-0","article-title":"A practical guide to the analysis of sirolimus using high-performance liquid chromatography with ultraviolet detection","volume":"22","author":"Napoli","year":"2000","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2004.09.004_bib43","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1042\/bj1730723","article-title":"Protein thiolation and reversible protein-protein conjugation. N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent","volume":"173","author":"Carlsson","year":"1978","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2004.09.004_bib44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.4023710","article-title":"Antibody-directed urokinase: a specific fibrinolytic agent","volume":"229","author":"Bode","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2004.09.004_bib45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/10731198309118804","article-title":"A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue","volume":"11","author":"Larm","year":"1983","journal-title":"Biomater. Med. Dev. Artif. Organs"},{"key":"10.1016\/j.jconrel.2004.09.004_bib46","unstructured":"Pierce Chemical Company Website. http:\/\/www.piercenet.com."},{"key":"10.1016\/j.jconrel.2004.09.004_bib47","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1208\/ps020107","article-title":"Synthesis and characterization of positively charged tPA as a prodrug using a heparin\/protamine-based drug-delivery system","volume":"2","author":"Liang","year":"2000","journal-title":"AAPS Pharmsci."},{"key":"10.1016\/j.jconrel.2004.09.004_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(90)90267-D","article-title":"Zero-length crosslinking procedure with the use of active esters","volume":"185","author":"Grabarek","year":"1990","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2004.09.004_bib49","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0008-6363(97)00168-5","article-title":"Predictors of luminal narrowing by neointima after angioplasty in atherosclerotic rabbits","volume":"36","author":"Gertz","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jconrel.2004.09.004_bib50","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.CIR.86.5.1536","article-title":"Effect of chronic subcutaneous or intramural administration of heparin on femoral artery restenosis after balloon angioplasty in hypercholesterolemic rabbits. A quantitative angiographic and histopathological study","volume":"86","author":"Gimple","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib51","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0741-5214(98)70167-3","article-title":"Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotypic change in vitro and neointimal formation in vivo","volume":"28","author":"Bingley","year":"1998","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.jconrel.2004.09.004_bib52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00019501-200205000-00008","article-title":"Twenty-eight-day efficacy and pharmacokinetics of the sirolimus-eluting stent","volume":"13","author":"Klugherz","year":"2002","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.jconrel.2004.09.004_bib53","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.CIR.0000034447.02535.D5","article-title":"Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation","volume":"106","author":"Degertekin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib54","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.0000034045.36219.12","article-title":"Angiographic findings of the multicenter randomized study with the sirolimus-eluting Bx velocity balloon-expendable stent (RAVEL). Sirolimus-eluting stents inhibit restenosis irrespective of the vessel size","volume":"106","author":"Regar","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib55","series-title":"Chemistry of Protein Conjugation and Cross-linking","author":"Wong","year":"1991"},{"key":"10.1016\/j.jconrel.2004.09.004_bib56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0014-4827(03)00120-4","article-title":"New cell attachment peptide sequences from conserved epitopes in the carboxy termini of fibrinogen","volume":"287","author":"Gorodetsky","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jconrel.2004.09.004_bib57","first-page":"195","article-title":"Detection of deep venous thrombi and pulmonary embolus with technetium-99m-DD-3B6\/22 anti-fibrin monoclonal antibody Fab' fragment","volume":"35","author":"Bautovich","year":"1994","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2004.09.004_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0168-3659(01)00270-X","article-title":"ATTEMPTS: a heparin\/protamine-based prodrug approach for delivery of thrombolytic drugs","volume":"72","author":"Liang","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2004.09.004_bib59","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/(SICI)1520-6017(200005)89:5<664::AID-JPS12>3.0.CO;2-9","article-title":"A novel heparin\/protamine-based pro-drug type delivery system for protease drugs","volume":"89","author":"Liang","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2004.09.004_bib60","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/01.CIR.102.10.1186","article-title":"Arterial remodeling. Mechanisms and clinical implications","volume":"102","author":"Ward","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib61","unstructured":"T. Clackson, Chemistry and biology of sirolimus analogs, http:\/\/www.tctmd.com\/expert-presentations."},{"key":"10.1016\/j.jconrel.2004.09.004_bib62","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1161\/01.CIR.0000070592.04766.36","article-title":"Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation","volume":"107","author":"Colombo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib63","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/01.CIR.0000062700.42060.6F","article-title":"Sirolimus-eluting stent implanted in human coronary artery for 16 months. Pathological findings","volume":"107","author":"Guagliumi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2004.09.004_bib64","unstructured":"Wyeth Pharmaceutical, Correction of drug information release, http:\/\/www.wyeth.com."},{"key":"10.1016\/j.jconrel.2004.09.004_bib65","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9149(02)02657-7","article-title":"Fate of side branches after coronary arterial sirolimus-eluting stent implantation","volume":"90","author":"Tanabe","year":"2002","journal-title":"Am. J. Cardiol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365904004377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365904004377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T13:56:48Z","timestamp":1549029408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365904004377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0168365904004377"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2004.09.004","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}